Monday, July 24, 2017 2:16:58 PM
Time Buy
26 nasd 0.041 1,800 0.038 0.041 14:00:07 1,800 565,991 0 1,450
25 nasd 0.04 60,000 0.038 0.04 13:59:29 60,000 564,191 0 1,450
24 nasd 0.04 10,000 0.038 0.04 13:58:05 10,000 504,191 0 1,450
23 nasd 0.039 110,000 0.038 0.039 13:57:42 110,000 494,191 0 1,450
22 nasd 0.039 14,390 0.038 0.039 13:57:12 14,390 384,191 0 1,450
21 nasd 0.039 10,000 0.038 0.039 13:57:08 10,000 369,801 0 1,450
20 nasd 0.0385 1,450 0.038 0.039 13:56:19 1,450 359,801 0 1,450
19 nasd 0.039 52,500 0.038 0.039 13:55:24 52,500 359,801 0 0
18 nasd 0.039 10,000 0.038 0.039 13:55:02 10,000 307,301 0 0
17 nasd 0.039 2,408 0.038 0.039 13:53:37 2,408 297,301 0 0
16 nasd 0.039 65,000 0.0375 0.039 13:53:30 65,000 294,893 0 0
15 nasd 0.039 10,000 0.0375 0.039 13:53:13 10,000 229,893 0 0
14 nasd 0.039 5,000 0.0375 0.039 13:30:03 5,000 219,893 0 0
13 nasd 0.0385 5,000 0.0375 0.039 13:29:56 5,000 214,893 0 0
12 nasd 0.039 55,000 0.0375 0.039 10:37:58 55,000 209,893 0 0
11 nasd 0.039 42,000 0.0375 0.039 10:33:35 42,000 154,893 0 0
10 nasd 0.039 2,500 0.0375 0.039 10:33:31 2,500 112,893 0 0
9 nasd 0.039 2,500 0.038 0.039 10:33:01 2,500 110,393 0 0
8 nasd 0.039 2,500 0.038 0.039 10:32:31 2,500 107,893 0 0
7 nasd 0.039 40,000 0.0375 0.039 09:54:25 40,000 105,393 0 0
6 nasd 0.039 30,000 0.0375 0.039 09:54:25 30,000 65,393 0 0
5 nasd 0.039 4,893 0.0375 0.039 09:50:52 4,893 35,393 0 0
4 nasd 0.039 10,000 0.0375 0.039 09:45:11 10,000 30,500 0 0
3 nasd 0.039 10,000 0.0375 0.039 09:45:10 10,000 20,500 0 0
2 nasd 0.039 500 0.0375 0.039 09:30:18 500 10,500 0 0
1 nasd 0.039 10,000 0.0375 0.039 09:30:18 10,000 10,000 0 0
Recent GOVX News
- GeoVax to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 09/03/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:15:02 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/30/2024 01:38:39 PM
- GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market • GlobeNewswire Inc. • 08/29/2024 12:59:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:19:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/21/2024 01:22:03 PM
- Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO • GlobeNewswire Inc. • 08/21/2024 01:00:00 PM
- GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market • GlobeNewswire Inc. • 08/20/2024 11:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:12:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:11:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:10:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:10:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:09:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:09:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:08:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:07:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:07:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:06:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:06:04 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/13/2024 04:15:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 12:47:49 PM
- GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board • GlobeNewswire Inc. • 08/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:05:39 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/06/2024 09:17:09 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/06/2024 09:16:20 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM